EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer
(Q79294407)
scientific article published on 23 October 2006
scientific article published on 23 October 2006
Language:
Current Data About
EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer
other details
description | scientific article published on 23 October 2006 |
External Links
(P356) |
10.1093/ANNONC/MDL323
|
(P698) |
17060486
|